SUMMARY Repeat DC countershock reproducibly results in myocardial necrosis in dogs. In this model, myocardial technetium99m pyrophosphate (PYP) uptake correlates linearly with tissue creatine kinase depletion (r = -0.83). The effect of pretreatment with methylprednisolone (MP) was studied with PYP in 25 dogs. In myocardium damaged by countershock, 12 MP dogs had higher tissue radioactivity sample:normal (S:N) ratios than control (P < 0.05), suggesting increased tissue injury. However, by several other measures of tissue damage, the two groups did not differ.
TECHNETIUM-99m STANNOUS PYROPHOS-PHATE (PYP) imaging is a newly developed approach to the assessment of myocardial injury. In acute myocardial infarction (MI) both myocardial imaging and tissue uptake studies demonstrate zones of necrosis as regions of increased radionuclide concentration." 2 This technique also identifies zones of abnormal PYP uptake following repeated DC countershock in dogs, an experimental model in which substantial myocardial necrosis is regularly produced.3 PYP distribution within a myocardial region is dependent upon at least two factors: tissue injury and a blood flowrelated delivery of the radiopharmaceutical to the injured zone."4 Because of this blood flow dependence, PYP tissue levels are not of value in determining the degree of necrosis following MI. However, in the canine countershock model, myocardial blood flow in regions of tissue necrosis is normal 24 hours following injury.3 Thus, myocardial PYP tissue levels in this model, as opposed to MI, should directly reflect the extent of regional necrosis.
Controversy still exists concerning whether corticosteroids modify the extent of ischemic necrosis following MI. Conflicting data have been presented in both clinical and experimental infarction.7 Countershock-induced myocardial necrosis represents a model where steroid pretreatment might modify tissue damage. In this model, PYP studies should provide relevant information.
This report describes experiments which utilize quantitative PYP techniques in the canine countershock model to assess the effects of corticosteroid pretreatment on the degree of myocardial injury. In the course of the study, our initial observations necessitated further evaluation of the effects of corticosteroids on PYP clearance and distribution. Multiposition precordial electrocardiographic recordings were made before and five and 60 minutes after countershock at 15 predetermined sites on the chest wall corresponding to five sites, from sternum to mid-axillary line, in the left fourth, fifth and sixth intercostal spaces. STsegment amplitude was measured in all recordings 0.08 sec after the onset of the QRS complex, with the PR segment taken as baseline. The sum of all ST amplitudes exceeding 2 mm (2ST) and the number of lead sites with such ST elevation (NST) were determined for each study.
Twenty-four hours following countershock, each dog received 10 mCi PYP intravenously. One hour later, the animals were sacrificed. Animals were then studied with a variety of techniques, which included tissue radioactivity measurements, quantitative imaging, tissue enzyme assay and histopathology.
In all dogs, the hearts were removed, trimmed of epicardial fat, and cut into approximately 25 1-2 g transmural samples. These samples included all grossly visible abnormal tissue, adjacent border zones, and five normal uninvolved samples from the posterior left ventricle. Samples were divided into epicardial and endocardial halves, weighed and counted for PYP activity (99mTc) in a Picker Spectroscaler IIIA well-type scintillation counter with a 3" X 3" sodium iodide crystal at a window of 100-140 keV. Sample radioactivity was calculated as counts per minute (cpm) per gram of tissue, corrected for decay of 9mTc, and normalized for injected dose. PYP activity in abnormal samples was also expressed as an activity ratio between the specific myocardial sample and the mean of five clearly normal samples obtained remote from the site of injury -the sample:normal (S:N) ratio. The mean of the five most abnormal S:N ratios was obtained for each animal.
In five hearts from control and four from MP treated dogs, 40-80 mg full-thickness portions of each tissue sample were assayed for creatine kinase (CK) activity according to previously described techniques.4 CK data in these nine animals were expressed both as activity ratios and as absolute activities (mIU/mg). The relationship between PYP uptake and CK depletion was analyzed further in fifty transmural samples from grossly abnormal zones as well as apparently normal border zones in three additional untreated countershock animals. CK and PYP activities each were expressed as S: N activity ratios.
A total of 26 transmural biopsies were taken for histopathologic study from eight control and eight MP dogs. Tissue was fixed in 10% formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin, Masson trichrome and hematoxylin basic fuchsin picric acid (HBFP) stains. Sections were examined for evidence of necrosis, edema and cellular reaction, and for depth of myocardial injury. The sections were graded semiquantitatively in a blind manner by one of the authors according to the following scheme: 0, no definite necrosis; 1+, scattered, mild, but definite necrosis; 2+, subepicardial necrosis (limited to outer ½/2 of myocardium) with moderate to severe tissue reaction; 3+, transmural necrosis (greater than ½/2 full-thickness) with moderate to severe tissue reaction.
Before dissection, seven excised hearts from each group were imaged quantitatively using a computerized multicrystal scintillation camera (Baird-Atomic System 77). The great vessels and atria were removed. The ventricles were opened and imaged en face with the anterior epicardial surface 5 cm from the parallel hole collimator. Computerized data processing of each image permitted expression of abnormal zone PYP uptake as radioactivity per unit area (counts/cm2).
Effects of MP on Plasma PYP Concentration and Metabolic Clearance
The uptake of PYP in myocardial tissue following MP could be influenced by altered levels of unbound radionuclide in plasma water or by changes in radionuclide clearance. Therefore, studies were performed to evaluate the effect of MP on the degree of plasma protein binding and on the metabolic clearance of PYP, as reflected by the rates of bone uptake and renal clearance of PYP. In these studies 10 animals (mean weight 19.4 i 0.9 kg) received MP (30 mg/kg i.v.) and 11 animals (mean weight 19.2 ± 0.8 kg) received its vehicle 24 hours prior to PYP injection, as in previous studies.
To determine the amount of PYP bound to plasma protein and to estimate levels of free radionuclide for clearance calculations, plasma was prepared from whole blood in five pairs of control and MP treated dogs. Plasma protein was precipitated using a modification of the method of Somogyi."' Direct determination of cpm of 9*mTc in plasma and the protein fraction in paired samples provided an estimate of the amounts of free and bound radionuclide.
The urinary excretion rate of PYP and fractional excretion rate of the radionuclide were determined in two groups of animals. In six pairs of control and MP animals, the clearance of PYP was calculated during the intravenous infusion of 5 percent dextrose in water (D5W), at a rate of 300 ml per hour. In the second group of five pairs of control and experimental animals, fractional excretion, Cpyp/Ccr, was determined during infusion of D5W at 450 ml per hour to facilitate accurate urine collections. Such water-loading would not be expected to alter Ccr or Cpyp measurements.
In this study exogenous creatinine (Cr) was administered initially in a bolus of 20 mg/kg in 20 ml of D5W, and then by constant infusion at 6 mg per minute to provide constant plasma levels. Clearance studies were begun 30 min before injection of PYP and were continued for 60 min thereafter. Urine collections were made at 10 min intervals and arterial blood samples were obtained for Cr and PYP levels before administration of the nuclide and at the end of each urine collection period. Plasma and urine Cr concentrations were measured on a Technicon autoanalyzer by a modification of the method of Folin and Wu."7
The renal clearance of PYP (Cypp) and creatinine (Ccr) was estimated from the expression C = 2 {(Ut * Vt)/Pt) /60 minutes, where Ut and Pt represent creatinine concentration (mg per ml) or PYP activity (cpm/ml) in 10 minute samples of urine and plasma, while Vt represents urine volume during each timed collection. The average value for 60 minutes after PYP injection was determined. In the dog, Ccr is a precise indicator of glomerular filtration rate (GFR).
In an additional six pairs of control and experimental animals, 2-3 g of cortical bone was excised (three samples per biopsy site) from the right and left fourth ribs, the posterior iliac crests and the femoral heads. All bone samples were weighed and counted for WmTc activity as described previously.
All statistical analyses were performed by the Student's ttest unless otherwise specified.
Results
Relationship between`mTc-PYP Uptake and CK Depletion in Countershock Injury
The validity of utilizing myocardial PYP uptake as an index of myocardial necrosis in the countershock model was examined by comparison of radionuclide levels with tissue CK depletion ( fig. 1) 2) . This difference initially suggested that the MP group sustained greater necrosis than control. However, absolute PYP radioactivity in abnormal zones (cpm/g/mCi) did not differ significantly in the two groups; in fact, the control group's mean was higher. Absolute PYP activity in the normal zone was, on the other hand, significantly less in the MP group (P < 0.025). Thus, the increased abnormality of the PYP S:N ratio in MP dogs would appear to be a function of reduced normal zone PYP activity rather than increased abnormal zone PYP activity. The latter condition would be expected if the change in the PYP activity ratio truly reflected increased tissue necrosis.
An estimate of abnormal zone mass was made by summing the weights of all epicardial and endocardial tissue samples with abnormal PYP accumulation, defined arbitrarily by a S: N ratio greater than 3:1.3 There was no significant difference between the MP dogs (10.3 + 1.1 g) and controls (10.4 + 1.2 g) ( fig. 3) . Likewise, abnormal zone PYP count densities derived from en face computerized imaging of the excised hearts did not significantly differ in the two groups ( fig. 3 ).
Effects of MP on Countershock Injury: CK Assessment and ST-Segment Mapping
There were no differences between the two groups in mean CK activity ratios, which were 0.21 0.06 in the control group and 0.24 ± 0.05 in the MP group (fig. 4) minutes after PYP injection was significantly reduced from the control level of 3.94 ± 0.62 to 2.27 ± 0.39 X 104 cpm/ml/mCi (P < 0.025) in the MP group. There was no difference in the amount of PYP bound to plasma protein, which averaged 83.4 ± 1.2% in controls and 77.7 ± 3.8% in experimental animals. Reduction in circulating PYP after MP could have resulted from changes in its metabolic clearance, either by increased urinary elimination or by increased uptake by bone, the principal PYP reservoir. Since an increase in urinary excretion of PYP could result from an increase in filtered load or from an alteration in the renal tubular handling of PYP, fractioij4l clearance studies were performed. tubule. In fact, PYP could be used as a tracer for measurement of GFR.
Renal PYP clearance measurements showed that MP markedly increased the urinary elimination of the nuclide during the 60 minute interval after administration ( fig. 6 ). Cpyp averaged 111.1 ± 13.4 ml/min in control dogs and 163.4 ± 25.7 ml/min in MP dogs (P < 0.05). Estimated as the amount of injected dose excreted within one hour, steroid-treated animals excreted 46.9 ± 3.6% of the initial dose, compared to 35.8 ± 2.5% in controls (P < 0.01).
These data indicate that in the MP group, an increase in filtered load of PYP, through an elevated GFR, significantly accelerated urinary PYP elimination.
In 22 Methylprednisolone, which has little or no mineralocorticoid effect, has been shown to increase inulin clearance in the dog and in the rat.23 24 The mechanism by which glucocorticoids increase GFR is not entirely clear, but several studies have demonstrated an associated increase in renal plasma flow. '8 19, 22, 24 These experiments were undertaken with the belief that countershock-induced myocardial necrosis would provide a situation where pharmacologic treatment prior to injury might be logically employed. However, in this model MP did not modify tissue damage. Several potential explanations exist: a) corticosteroids may not truly reduce myocardial injury; b) the electrical energy employed in these experiments may have been too great to permit salvage of myocardium; c) countershock necrosis may differ from ischemic necrosis in the potential for tissue salvage. The issue of corticosteroid-related reduction in the extent of injury following myocardial infarction remains controversial. The most frequently offered explanation for corticosteroid modification of cellular injury involves stabilization of biomembranes, including lysosomal membranes. 25 27 Countershock injury differs pathologically from ischemic injury. Certain non-ischemic cellular injuries, such as countershock, result from direct attack on the cell membrane, and cause rapid, uniform cell death and lysis. Two histopathologic hallmarks distinguish countershock injury from ischemic coagulation necrosis: a) an immediate cytoplasmic disorganization; and b) the absence of major polymorphonuclear leukocyte infiltration.28' 29 These changes, occurring in the presence of an intact microcirculation, appear to fit into the pattern of myofibrillar degeneration. 30 The possibility that countershock necrosis and ischemic infarction originate as different forms of injury could, in part, explain different responses to corticosteroid intervention.
Effects of corticosteroids on myocardial metabolism and hemodynamics have been studied intensively. Corticosteroids appear to increase coronary blood flow, an effect of potential relevance for salvage of ischemic myocardium.'0' 31-S3 If myocardial blood flow was increased by MP administration in our experiments, then myocardial delivery of PYP increased as well. This conceivably resulted in increased myocardial radionuclide uptake. However, abnormal zone PYP uptake was not different in the two groups, and normal zone PYP activity was clearly less in MP dogs than control. This indicates that augmented myocardial blood flow, if present, potentially opposed and minimized the observed effect on myocardial PYP distribution.
